NEOMYCIN SULFATE vs TOBI PODHALER

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. NEOMYCIN SULFATE and TOBI PODHALER are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	NEOMYCIN SULFATE	TOBI PODHALER
Rating	48/100	70/100
Pharmacy pays	~$25.36 /30	$1.08 /mL
Type	RX	RX
Active ingredient	NEOMYCIN SULFATE	TOBRAMYCIN
Manufacturer	Teva	Viatris
Dosage forms	Topical, Tablet	Capsule
Drug class	Aminoglycoside Antibacterial	Aminoglycoside Antibacterial
Boxed warning	Boxed warning	None
Treats	Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases	Infectious Bone Diseases, Central Nervous System Infections, Pseudomonas Infections

neomycin sulfate tobi podhaler

Rating

48/100

70/100

Pharmacy pays

~$25.36 /30

$1.08 /mL

Type

Active ingredient

NEOMYCIN SULFATE

TOBRAMYCIN

Manufacturer

Teva

Viatris

Dosage forms

Topical, Tablet

Capsule

Drug class

Aminoglycoside Antibacterial

Boxed warning

None

Treats

Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases

Infectious Bone Diseases, Central Nervous System Infections, Pseudomonas Infections

Frequently asked questions

Which is better-rated, Neomycin Sulfate or Tobi Podhaler?

By our independent rating, Tobi Podhaler scores higher — 3.5 vs 2.4 out of 5 for Neomycin Sulfate. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Neomycin Sulfate and Tobi Podhaler?

Neomycin Sulfate contains Neomycin Sulfate, while Tobi Podhaler contains Tobramycin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.